Skip to main content
Clinical Trials/ISRCTN83308122
ISRCTN83308122
Completed
Not Applicable

Six-month clinical trial to investigate the effect of Hintonia latiflora in the dietetic treatment of mild and moderate type 2 diabetes mellitus

Gehrlicher Pharmazeutische Extrakte GmbH (Germany)0 sites40 target enrollmentSeptember 7, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild and moderate diabetes mellitus of type II (age-related)
Sponsor
Gehrlicher Pharmazeutische Extrakte GmbH (Germany)
Enrollment
40
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2012
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Gehrlicher Pharmazeutische Extrakte GmbH (Germany)

Eligibility Criteria

Inclusion Criteria

  • 1\. Type 2 diabetics
  • 2\. Between the ages of 45 and 80
  • 3\. Neither oral antidiabetic agents nor insulin were used
  • 4\. Prescribed diet had led to stable but not nearly normoglycaemic values
  • As a condition for inclusion in the study, diabetic symptoms must have existed for a period of at least 12 months. The values for fasting blood sugar had to be in the range from 7\-14 mmol/l (normal value: 3\.9\-5\.4 mmol/l).

Exclusion Criteria

  • To be excluded were patients for whom there was a doubt about the reliability with respect to the adherence to the dietetic guidelines (e.g., with regard to alcohol consumption). Other exclusion reasons were severe diabetic symptoms, progressive life\-threatening diseases, hepatic dysfunction or renal insufficiency (deviations of GOT, ?GT and AP of more than twice the normal value, serum creatinine \> 130 µmol/l), hypoglycaemic crises not noticed in time, retinopathy, pregnancy, malignant tumours and/or drug or alcohol dependence in the medical history.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical trial to evaluate the influence of 6 day-dexamethasone (inducer of CES1)Diseases of th respiratory system
KCT0001533Bundang CHA General Hospital20
Completed
Phase 2
Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myoma
JPRN-UMIN000026073Department of Obstetrics and Gynecology Nara Medical University80
Completed
Not Applicable
Effectiveness of a Herbal and Nutritional Supplement on Cognitive Function in Older Adults with Subjective Cognitive Impairment
ACTRN12617000945325Mrs Adele Cave100
Active, not recruiting
Phase 1
Efficacy study to evaluate fluticasone furoate /vilanterol Inhalation Powder delivered once daily via the Dry Powder Inhaler Ellipta™ compared with usual ICS/LABA maintenance therapy delivered by Dry Powder Inhaler in subjects with Persistent AsthmaSubject with persistent asthmaMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2014-000551-81-DEGlaxoSmithKline Research & Development Limited422
Recruiting
Not Applicable
Clinical study over a period of at least 6 months to an individualized strength and endurance training in COPD patients in MarburgerJ44.8Other specified chronic obstructive pulmonary disease
DRKS00006842Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany, Member of the German Center for Lung Research (DZL)48